Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 316

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Berberine: a potential phytochemical with multispectrum therapeutic activities

Vuddanda, Parameswara Rao, Chakraborty, Subhashis, Singh, Sanjay · 2010 · Expert Opinion on Investigational Drugs

Abstract

IMPORTANCE OF THE FIELD: The use of traditional medicines of natural origin is being encouraged for the treatment of chronic disorders, as synthetic drugs in such cases may cause unpredictable adverse effects. Berberine, a traditional plant alkaloid, is used in Ayurvedic and Chinese medicine for its antimicrobial and antiprotozoal properties. Interestingly, current clinical research on berberine has revealed its various pharmacological properties and multi-spectrum therapeutic applications. AREAS COVERED IN THIS REVIEW: An extensive search in three electronic databases (Unbound Medline, PubMed and ScienceDirect) and internet search engines (Scirus and Google Scholar) were used to identify the clinical studies on berberine, without any time constraints. This review elaborates the recent studies which reveal that with time, the drug has evolved with superior therapeutic activities. In addition, this review will also attract the attention of formulation scientists towards the issues and challenges associated in its drug delivery and the probable approaches that may be explored to help patients reap the maximum benefit of this potentially useful drug. WHAT THE READER WILL GAIN: A relatively large number of studies discussed here have revealed the possible areas where this phytochemical constituent can exhibit its therapeutic activities in the treatment of chronic ailments or diseases including diabetes, cancer, depression, hypertension and hypercholesterolemia. TAKE HOME MESSAGE: The potential of the drug remains to be harvested by designing a suitable formulation that could overcome its inherent low bioavailability.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/13543784.2010.517745

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 21

  1. Patwardhan B, 1992, J Altern Complement Med, 3, 9
  2. Arayne MS, 2007, Pak J Pharm Sci, 20, 83
  3. Chevalier A. Encyclopedia of medicinal plants, Revised Edition. Sydney (AUS): Dorling Kindersley; 2001
  4. Sack RB, 2000, Altern Med Rev, 5, 175
  5. 10.1016/0014-4894(85)90047-5 · doi:10.1016/0014-4894(85)90047-5
  6. Kaneda Y, 1990, Tokai J Exp Clin Med, 15, 417
  7. Nair KP, 1970, Pediatr Clin India, 5, 45
  8. Choudhry VP, 1972, Indian Pediatr, 9, 143
  9. Sheng WD, 1997, East Afr Med J, 74, 283
  10. Swabb EA, 1981, Am J Physiol, 241, G248
  11. Yuan J, 1994, Zhongguo Zhong Xi Yi Jie He Za Zhi, 14, 718
  12. Szeto S, 2002, Turk J Med Sci, 32, 363
  13. Cicero AF, 2007, Arzneimittelforschung, 57, 26
  14. Olmez E, 1992, Arzneimittelforschung, 42, 1095
  15. 10.2165/00137696-200604040-00008 · doi:10.2165/00137696-200604040-00008
  16. 10.1016/j.ijpharm.2006.01.020 · doi:10.1016/j.ijpharm.2006.01.020
  17. Sachs-Barrable K, 2007, J Pharm Pharm Sci, 10, 319
  18. 10.1016/S0021-9673(02)00378-3 · doi:10.1016/s0021-9673(02)00378-3
  19. Lai J, 2010, Int J Nanomedicine, 5, 13
  20. Xin HW, 2002, Chin Pharmacol Bull, 18, 397
  21. Gui SY, 2008, Pharmazie, 63, 516

Cited by

See all 316

Metadata

Authors
Vuddanda, P. R., Chakraborty, S., & Singh, S.
Venue
Expert Opinion on Investigational Drugs
Published
2010-09-13
Volume
19
Issue
10
Pages
1297-1307
ISSN
  • 1354-3784 (ISSN-L)
  • 1744-7658
OpenAlex
W2076903615
Cited by
316
References
64
FWCI
11.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.